Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status

International Journal of Cancer

Volumn 71, Issue 2, 1997, Pages 196-202

  Chen, Yi Ming A ^a   Chen, Shiu Hung ^a   Fu, Chong Yau ^a   Chen, Jeou Yuan ^b   Osame, Mitsuhiro ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISERUM; PROTEIN P53; RECOMBINANT PROTEIN; REX PROTEIN; STRUCTURAL PROTEIN; TAX PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA;

ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; GENE PRODUCTS, REX; GENE PRODUCTS, TAX; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMANS; LEUKEMIA, T-CELL; PARAPARESIS, TROPICAL SPASTIC; PLASMIDS; POLYMERASE CHAIN REACTION; RABBITS; RETROVIRIDAE PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030954219     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970410)71:2<196::AID-IJC12>3.0.CO;2-G     Document Type: Article

References (38)

1. BERNEMAN, Z.N., GARTNHAUS, R.B., REITS, M.S., JR., BLATTNER, W.A., MANNS, A., HANCHARD, B., IKEHARA, O., GALLO, R.C. and KLOTMAN, M.K., Expression of alternatively spliced human T-lymphotropic virus type-I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. nat. Acad. Sci. (Wash.), 89, 3005-3009 (1992).
2. CESARMAN, E., CHADBURN, A., INGHIRAMI, G., GAIDANO, G. and KNOWLES, D.M., Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood, 80, 3205-3216 (1992).
3. CHEN, J.-Y., FUNK, W.D., WRIGHT, W.E., SHAY, J.W. and MINNA, J.D., Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene. 8, 2159-2166 (1993).
4. CHEN, Y.-M.A., OKAYAMA, A., LEE, T.H., TACHIBANA, N., MUELLER, N. and ESSEX, M., Sexual transmission of HTLV-I associated with the presence of the anti-tax antibody. Proc. nat. Acad. Sci. (Wash.), 88, 1182-1186 (1991a).
5. CHEN, Y.-M.A, and SANKALE, J.-L., Other human retroviruses. In: M. Essex, S. Mboup, P.J. Kanki and M.R. Kalengayi (eds.), AIDS in Africa, pp. 67-95, Raven, New York (1994).
6. CHEN, Y.-M.A., ZHANG, X., DAHL, C.E., SAMUEL, K.P., SCHOOLEY, R.T., ESSEX, M. and PAPAS, T.S., Delineation of type-specific regions on human. T-cell leukemia virus envelope glycoproteins. J. Immunol., 147, 2368-2376 (1991b).
7. CIMINALE, V., PAVLAKIS, G.N., DERSE, D., CUNNINGHAM, C.P. and FELBER, B.K., Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J. Virol., 66, 1737-1745 (1992).
8. DERSE, D., Construction of activator-dependent retroviral vectors based on HTLV-I and BLV. In: RNA tumor viruses meeting p. 209. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
9. GELMANN, E.P., FRANCHINI, G., MANZARI, V., WONG-STAAL, F. and GALLO, R.C., Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). Proc. nat. Acad. Sci. (Wash.), 81, 993-997 (1984).
10. GESSAIN, A., BARIN, F., VERNANT, J.C., GOUT, O., MAURS, L., CALENDER, A. and DE-THÉ, G., Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet, ii, 407-410 (1985).
11. GUAN, K.L. and DIXON, J.E., Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem., 192, 262-267 (1991).
12. HIDAKA, M., INOUE, J., YOSHIDA, M. and SEIKI, M., Post-transeriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J., 7, 519-523 (1988).
13. 8+ cyiotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-associated neurological disease. Nature (Lond.), 348, 245-248 (1990).
14. tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection. Jap. J. Cancer Res., 80, 1066-1071 (1989).
15. KINOSHITA, T., SHIMOYAMA, M., TOBINAI, K., ITO, M., ITO, S., IKEDA, S., TAJIMA, K., SHIMOTOHNO, K. and SUGIMURA, T., Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuelear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction, Proc. nat. Acad. Sci. (Wash.), 86, 5620-5624 (1989).
16. II proteins encoded by human T-eell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol., 67, 2360-2366 (1993).
17. KORALNIK, I.J., GESSAIN, A., KLOTMAN, M.E., LOMONICO, A., BERMEMAN, Z.N. and FRANCHINI, G., Protein isoforms encoded by the pX region of human T-eell leukemia/lymphotropic virus type I. Proc. nat. Acad. Sci. (Wash.), 89, 8813-8817 (1992).
18. LAL, R.B., GIAM, C.-Z., COLIGAN, J.E. and RUDOLPH, D.L., Different immune responsiveness to the immunodominant epitopes of regulatory protein (tax and rex) in human T cell lymphotropic virus type-I associated myelopathy. J. infect. Dis., 169, 496-503 (1994).
19. LEE, T.H., COLIGAN, J.E., SODROSKI, J.G., HASELTINE, W.A., SALAHUDDIN, S.Z., WONG-STAAL, K. GALLO, R.C. and ESSEX, M. Antigens encoded by the 3′-terminal region of human T-cell leukemia virus: evidence for a functional gene. Science (Wash.), 226, 57-61 (1984).
20. I with IL-2 β-chain receptor: mapping of the interacting domains of both proteins, In: Retroviruses meeting, P. 313. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1993).
21. NAGAI, H., KINOSHITA, T., IMAURA, J., MURAKAMI, Y., HAYASHI, K., MUKAI, K., IKEDA, S., TOBINAI, K., SAITO, H., SHIMOYAMA, M. and SHIMOTOHNO, K., Genetic alteration of p53 in some patients with adult T-cell leukemia. Jap. J. Cancer Res., 82, 1421-1427 (1991).
22. OKAYAMA, A., CHEN, Y.-M.A., TACHIBANA, N. SHIOIRI, S., LEE, T.H., TSUDA, K. and ESSEX, M., High incidence of antibodies to HTLV-I tax in blood relatives of adult T-cell leukemia patients. J. infect. Dis., 163, 47-52 (1991).
23. OSAME, M., USUKU, K., IZUMO, S., IJICHI, N., AMITANI, H., IGATA, A., MATSUMOTO, M. and TARA, M., HTLV-I associated myelopathy, a new clinical entity. Lancet, i, 1031-1032 (1986).
24. POIESZ, B.J., RUSCETTI, F.W., GAZDAR, A.F., BUNN, P.A., MINNA, J.D. and GALLO, R.C., Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. nat. Acad. Sci. (Wash.), 77, 7415-7419 (1980).
25. REID, R.L., LINDHOLM, P.P., MIRESKANDARI, A., DITTMER, J. and BRADY, J.N., Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene, 8, 3029-3036 (1993).
26. rex or envelope expression. J. Virol, 68, 3448-3451 (1994).
27. SAKASHITA, A., HATTORI, T., MILLER, C.W., SUZUXHIMA, H., ASOU, N., TAKATSUKI, K. and KOEFFLER, H.P., Mutation of the p53 gene in adult T-cell leukemia. Blood, 79, 477-480 (1992).
28. SALAHUDDIN, S.Z., MARKHA, P.D., LINDNER, S.G., GOOTENBERG, J., POPOVIC, M., HEMMI, H., SARIN, P.S. and GALLO, R.C., Lymphokine production by cultured human T cells transformed by human T-cell leukemia/ lymphoma virus-I. Science (Wash.), 223, 703-707 (1984).
29. SANG, B.-C., CHEN, J.-Y., MINNA, J. and BARBOSA, M.S., Distinct regions of p53 have a different role in transcriptional activation and repression functions. Oncogene, 9, 853-859 (1994).
30. SCHLICHTHOLZ, B., LEGROS, Y., GILLET, D., GAILLAND, C., M., ARTY, M., LANE, D., CALVO, F. and SOUSSI, T., The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res., 52, 6380-6384 (1992).
31. SMITH, D.B. and JOHNSON, K.S., Single-step purification of polypeptides expressed in Escherichia coli as fusion with glutathione S-transferase. Gene, 67, 311-40 (1988).
32. SODROSKI, J., ROSEN, C., GOH, W.C. and HASELTINE, W.A., Transcriptional activator protein encoded by the X-lor region of the human T-cell leukemia virus. Science (Wash.), 228, 1430-1434 (1985).
33. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer. 57, 1-9 (1994).
34. SUGITO, S., YAMATO, K., SAMESHIMA, Y. YOKATA, J., YANO, S. and MIYOSHI, I., Adult T-cell leukemia: structures and expression of the p53 gene. Int. J. Cancer, 49, 880-885 (1990).
35. SZEKRLY, L., SELIVANOVA, G., MAGNUSSON, K.P., KLEIN, G. and WIMAN, K.G., EBNA-5, an Epsiein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. nAt. Acad. Sci. (Wash.), 90, 5455-5459 (1993).
36. WANG, X.W., FORRESTER, K., YEH, H., FEITFLSON, M.A., GU, J.-R. and HARRIS, C.C., Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. nat. Acad. Sci. (Wash.), 91, 2230-2234 (1994).
37. WERNESS, B.A., LEVINE, A.J. and HOWLEY, P.M., Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science (Wash.), 248, 76-79 (1990).
38. YAMATO, K., OKA, T., HIROI, M., IWAHARA, Y. SUGITO, S., TSUCHIDA, N. and MIYOSHI, I. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infccted cells. Jap. J. Cancer Res., 84, 4-8 (1993).